Latest financial market updates and expert analysis
Analysis Ocugen has given investors a fresh look under the hood of its gene therapy pipeline — and in doing so, quietly changed the yardstick by which its lead program will...
2G Energy finds itself pulled in two directions. On one side stands a fresh endorsement from SMC Research, which lifted...
Roughly 700 IG Metall shop-floor representatives at Audi have closed ranks behind a single demand: no more savings packages at...
AST SpaceMobile has spent the past several weeks stacking up operational wins. A completed network integration test with TELUS. Three...
Moderna’s 8.0% drop on Friday should be read as a warning against inflated expectations, not as evidence of an operational...
Albemarle shares closed Friday at 84.96 euros, down 3.0 percent, as a wave of risk aversion across US equity markets...
Ocugen has reaffirmed the regulatory timeline for its lead gene therapy, OCU400, even as the company’s shares continue to languish...
Caterpillar rolled out five new compact machines on Friday, a product push that broadens its catalogue but leaves the central...
Vertiv shares gave up 4.3% yesterday, caught in a technology-wide downdraft that also dragged down fellow data-center suppliers Comfort Systems...
TSMC has made plain what it wants from any tie-up with Elon Musk’s Terafab venture: the keys to the factory...
BioNTech shares closed Friday at EUR 78.05, down 3.0% on the session, capping a bruising stretch for the Mainz-based vaccine...
